Literature DB >> 20056799

Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro.

Caroline E Rutten, Simone A P van Luxemburg-Heijs, Edith D van der Meijden, Marieke Griffioen, Machteld Oudshoorn, Roel Willemze, J H Frederik Falkenburg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20056799     DOI： 10.1182/blood-2009-10-249821

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.

Authors:  W Herr; Y Eichinger; J Beshay; A Bloetz; S Vatter; C Mirbeth; E Distler; U F Hartwig; S Thomas
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

2.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

3.  Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

Authors:  K Fleischhauer; K W Ahn; H L Wang; L Zito; P Crivello; C Müller; M Verneris; B E Shaw; J Pidala; M Oudshorn; S J Lee; S R Spellman
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

4.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

Authors:  Jeffrey S Miller; Edus H Warren; Marcel R M van den Brink; Jerome Ritz; Warren D Shlomchik; William J Murphy; A John Barrett; Hans Jochem Kolb; Sergio Giralt; Michael R Bishop; Bruce R Blazar; J H Frederik Falkenburg
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-10       Impact factor: 5.742

5.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

6.  Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Authors:  Betül Oran; Rima M Saliba; Yudith Carmazzi; Marcos de Lima; Gabriela Rondon; Sairah Ahmed; Amin Alousi; Borje S Andersson; Paolo Anderlini; Michelle Alvarez; Qasier Bashir; Stefan Ciurea; Marcelo Fernandez-Vina; Chitra Hosing; Partow Kebriaei; Martin Korbling; Pedro Cano; Issa Khouri; David Marin; Yago Nieto; Amanda Olson; Uday Popat; Katy Rezvani; Muzaffar Qazilbash; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Blood       Date:  2018-01-31       Impact factor: 22.113

7.  High HLA-DP Expression and Graft-versus-Host Disease.

Authors:  Effie W Petersdorf; Mari Malkki; Colm O'hUigin; Mary Carrington; Ted Gooley; Michael D Haagenson; Mary M Horowitz; Stephen R Spellman; Tao Wang; Philip Stevenson
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

Review 8.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

Authors:  Edus H Warren; Xinyi Cindy Zhang; Shuying Li; Wenhong Fan; Barry E Storer; Jason W Chien; Michael J Boeckh; Lue Ping Zhao; Paul J Martin; John A Hansen
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

9.  HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation.

Authors:  Sebastian Klobuch; Kathrin Hammon; Sarah Vatter-Leising; Elisabeth Neidlinger; Michael Zwerger; Annika Wandel; Laura Maria Neuber; Bernhard Heilmeier; Regina Fichtner; Carina Mirbeth; Wolfgang Herr; Simone Thomas
Journal:  Cells       Date:  2020-05-20       Impact factor: 6.600

10.  In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.

Authors:  C Burt; A Parker; G McQuaker; M Copland; C Brierley; A-M Little; A Clark
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.